FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

EUCAIM

EUCAIM: European Federation for Cancer Images

Topic: DIGITAL-2022-CLOUD-AI-02-CANCER-IMAGE – Federated European infrastructure for cancer images data

Type of Action: DIGITAL Simple Grants

Duration: 48 months

Start date: 1 January 2023

Grant agreement: 101100633

Web: https://cancerimage.eu/

Total request Grant by Consortium: €17,789,829.02

Total request Grant by BBMRI-ERIC: €252,680.50

Linked Third Parties/BBMRI-ERIC Framework Agreement:

Benefit/tasks for BBMRI-ERIC: BBMRI-ERIC contributes to:

WP2  (Engagement and Liaison of Data Providers)

WP3  (Ethical and Legal Aspects)

WP4  (Governance and Implementation of the Central Hub)

WP5  (Data Federation and Interoperability Framework)

WP6  (Federated data processing and analysis)

WP7  (Use cases for platform expansion and validation)

WP8  (Business & Sustainability models)

Additional Information

The EUropean Federation for CAncer IMages (EUCAIM) is a part of the European Commission-initiated European Cancer Imaging Initiative, which aims to foster innovation and deployment of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients.

EUCAIM’s aim is to build a pan-European digital federated infrastructure of cancer-related images which will be used for the development of AI tools toward precision medicine. The hope is that this infrastructure will provide the means to develop AI tools that will be able to enhance the (cancer) diagnosis procedure, treatment and the identification of the need for predictive medicine benefiting patients across Europe.


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept